We are live on
!
Find out more
SC
Sophrosyne Capital Portfolio holdings
AUM
$11.5M
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
+16.82%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$37M
(-24%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-37.45%
Top 10 Holdings %
Top 10 Hldgs %
55.88%
Holding
85
New
18
Increased
11
Reduced
34
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arcturus Therapeutics
ARCT
|
+$3.67M |
| 2 |
FLNA
Filana Therapeutics
FLNA
|
+$3.22M |
| 3 |
CYNI
CYAN INC COM
CYNI
|
+$2.12M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$2.04M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIGA Technologies
SIGA
|
+$4.46M |
| 2 |
AeroVironment
AVAV
|
+$4.42M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$4.02M |
| 4 |
Calix
CALX
|
+$3.41M |
| 5 |
SANW
S&W Seed Co
SANW
|
+$3.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.14% |
| 2 | Technology | 27.01% |
| 3 | Communication Services | 7.3% |
| 4 | Utilities | 3.88% |
| 5 | Miscellaneous | 3.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Safe Bulkers
SB
$857M
| $203K | 0.18% |
19,561
-11,200
| -36% | -$88.9K |
|
|
AVG
52
DELISTED
AVG Technologies N.V.
AVG
| $172K | 0.15% |
+10,000
| New | +$194K |
|
53
Xylem
XYL
$26.3B
| $166K | 0.15% |
+4,800
| New | +$154K |
|
54
CrossAmerica Partners
CAPL
$888M
| $157K | 0.14% |
5,500
+500
| +10% | +$14K |
|
|
55
AeroVironment
AVAV
$7.74B
| $152K | 0.13% |
5,200
-164,226
| -97% | -$4.42M |
|
|
TPH
56
DELISTED
Tri Pointe Homes
TPH
| $134K | 0.12% |
+6,700
| New | +$115K |
|
57
Canadian Pacific Kansas City
CP
$82.5B
| $121K | 0.11% |
4,000
-3,175
| -44% | -$91.5K |
|
|
GLOG
58
DELISTED
GASLOG LTD
GLOG
| $121K | 0.11% |
7,100
-2,500
| -26% | -$38.5K |
|
59
SLB Ltd
SLB
$81.6B
| $117K | 0.1% |
+1,300
| New | +$117K |
|
|
CVGW
60
DELISTED
Calavo Growers
CVGW
| $115K | 0.1% |
+3,800
| New | +$113K |
|
|
SYT
61
DELISTED
Syngenta Ag
SYT
| $108K | 0.09% |
1,350
-950
| -41% | -$75.1K |
|
62
Adecoagro
AGRO
$1.54B
| $97K | 0.08% |
12,000
-2,300
| -16% | -$18.3K |
|
63
Sabesp
SBS
$17B
| $86K | 0.08% |
+39,190
| New | +$80.7K |
|
64
American Water Works
AWK
$27.2B
| $80K | 0.07% |
+1,900
| New | +$79.6K |
|
65
Enterprise Products Partners
EPD
$84.3B
| $40K | 0.04% |
1,200
-1,200
| -50% | -$37.4K |
|
66
Assembly Biosciences
ASMB
$709M
| – | – |
-3,681
| Closed | -$637K |
|
67
Altisource Portfolio Solutions
ASPS
$63.7M
| – | – |
-1,688
| Closed | -$1.89M |
|
|
CPRX
68
DELISTED
Catalyst Pharmaceutical
CPRX
| – | – |
-239,760
| Closed | -$732K |
|
69
Ecolab
ECL
$80.1B
| – | – |
-1,100
| Closed | -$109K |
|
70
Lifecore Biomedical
LFCR
$172M
| – | – |
-14,900
| Closed | -$182K |
|
71
Meta Platforms (Facebook)
META
$1.45T
| – | – |
-23,900
| Closed | -$1.2M |
|
|
SDEV
72
Stablecoin Development Corp
SDEV
$49.5M
| – | – |
-11
| Closed | -$2.77M |
|
73
Nektar Therapeutics
NKTR
$2.55B
| – | – |
-9,140
| Closed | -$1.43M |
|
74
Nuwellis
NUWE
$3.14M
| – | – |
0
| – | -$1.4M |
|
|
75
SIGA Technologies
SIGA
$220M
| – | – |
-1,167,185
| Closed | -$4.46M |
|
Similar funds
SFM
IACGFA
LS
NGPI
AP
GRP
NVPV
AC
Sophrosyne Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Sophrosyne Capital held 85 positions worth $114M, down 24% from $151M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Sophrosyne Capital withdrew a net $42.8M in Q4 2013, closing 19 positions and reducing 34 holdings. Its most notable exit was SIGA Technologies, an estimated $4.46M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 50% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Sophrosyne Capital opened a new position in CYAN INC COM worth $1.88M.
- Sophrosyne Capital's largest Q4 2013 buy was CYAN INC COM: 354,699 shares worth $1.88M.
- Sophrosyne Capital added most to Arcturus Therapeutics in Q4 2013, an estimated $3.67M increase.
- Sophrosyne Capital's biggest Q4 2013 reduction was AeroVironment, cutting an estimated $4.42M.
- Sophrosyne Capital fully exited SIGA Technologies in Q4 2013, selling an estimated $4.46M.
- Sophrosyne Capital's ten largest holdings make up 56% of its $114M portfolio in Q4 2013.
- Sophrosyne Capital opened 18 new positions and closed 19 in Q4 2013.
- Sophrosyne Capital's portfolio value fell 24% quarter-over-quarter to $114M.
Based on Sophrosyne Capital's 13F filing for Q4 2013, filed 13 Feb 2014.